risperidone has been researched along with Pregnancy in 68 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A search of the Benefit Risk Management Worldwide Safety database, using a selection of preferred terms from the Medical Dictionary of Regulatory Activities, was performed to identify all cases of pregnancy or fetal/neonatal outcomes reported in association with risperidone treatment from its first market launch (international birth date, 1 June 1993) to 31 December 2004." | 8.84 | Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes. ( Coppola, D; Kwarta, RF; Russo, LJ; Schmider, J; Varughese, R, 2007) |
| "This study aimed to determine the effects of pregnancy and ontogeny on risperidone and paliperidone pharmacokinetics by assessing their serum concentrations in two subjects and constructing a customized physiologically-based pharmacokinetic (PBPK) model." | 8.31 | Physiologically-based pharmacokinetic model to investigate the effect of pregnancy on risperidone and paliperidone pharmacokinetics: Application to a pregnant woman and her neonate. ( Fujioka, K; Fujiwara, N; Horai, T; Iijima, K; Imafuku, H; Ito, T; Mahdy, WYB; Omura, T; Otsuka, I; Yamamoto, K; Yano, I, 2023) |
| "While numerous studies have confirmed the efficacy of risperidone long-acting injectable (RLAI) on many clinical outcomes in patients with schizophrenia, there is no data regarding its influence on employment status." | 7.83 | Remission and employment status in schizophrenia and other psychoses: One-year prospective study in Croatian patients treated with risperidone long acting injection. ( Emsley, R; Filipcic, IS; Grosic, V; Mihaljevic-Peles, A; Pedisic, I; Sagud, M, 2016) |
| "The aims of this study were to investigate bone mass, body composition and light microscopic pathology examinations of femur in an animal model of schizophrenia (pharmacologically induced by postnatally administered phencyclidine-PCP) and to further examine the effects of chronic treatment with risperidone on these parameters in rats." | 7.79 | Chronic risperidone exposure does not show any evidence of bone mass deterioration in animal model of schizophrenia. ( Doknic, M; Jasovic-Gasic, M; Maric, N; Pekic, S; Petronijevic, M; Petronijevic, N; Popovic, V; Radonjic, N; Sopta, J, 2013) |
| "Data on the use of long-acting injectable (LAI) risperidone, the first atypical depot antipsychotic, during pregnancy are limited." | 7.74 | Use of long-acting injectable risperidone before and throughout pregnancy in schizophrenia. ( Kim, JM; Kim, KM; Kim, SW; Shin, HY; Shin, IS; Yang, SJ; Yoon, JS, 2007) |
| "A follow-up of a case of pregnancy with risperidone microspheres is reported." | 7.73 | Follow-up of a pregnancy with risperidone microspheres. ( Dabbert, D; Heinze, M, 2006) |
| " The parturient developed exaggerated hypotension, refractory to conventional treatment with ephedrine and IV fluids, that eventually responded to large doses of phenylephrine." | 7.72 | Risperidone and exaggerated hypotension during a spinal anesthetic. ( Hepner, DL; Williams, JH, 2004) |
| "Schizophrenia is a disorder of a neurodevelopmental origin manifested symptomatically after puberty." | 5.37 | Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia. ( Arad, M; Piontkewitz, Y; Weiner, I, 2011) |
| "Valnoctamide could be an important valproate substitute for women of childbearing age with bipolar disorder who may become pregnant." | 5.14 | Valnoctamide as a valproate substitute with low teratogenic potential in mania: a double-blind, controlled, add-on clinical trial. ( Agam, G; Applebaum, J; Belmaker, RH; Bersudsky, Y; Gaiduk, Y; Mishory, A; Podberezsky, A; Sharony, L, 2010) |
| "A search of the Benefit Risk Management Worldwide Safety database, using a selection of preferred terms from the Medical Dictionary of Regulatory Activities, was performed to identify all cases of pregnancy or fetal/neonatal outcomes reported in association with risperidone treatment from its first market launch (international birth date, 1 June 1993) to 31 December 2004." | 4.84 | Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes. ( Coppola, D; Kwarta, RF; Russo, LJ; Schmider, J; Varughese, R, 2007) |
| "This study aimed to determine the effects of pregnancy and ontogeny on risperidone and paliperidone pharmacokinetics by assessing their serum concentrations in two subjects and constructing a customized physiologically-based pharmacokinetic (PBPK) model." | 4.31 | Physiologically-based pharmacokinetic model to investigate the effect of pregnancy on risperidone and paliperidone pharmacokinetics: Application to a pregnant woman and her neonate. ( Fujioka, K; Fujiwara, N; Horai, T; Iijima, K; Imafuku, H; Ito, T; Mahdy, WYB; Omura, T; Otsuka, I; Yamamoto, K; Yano, I, 2023) |
| " Peak prolactin levels/any hyperprolactinemia/triple-upper-limit-of-normal-prolactin level were highest with risperidone (median = 56." | 4.31 | Antipsychotic-Related Prolactin Levels and Sexual Dysfunction in Mentally Ill Youth: A 3-Month Cohort Study. ( Carlson, HE; Correll, CU; Kazimi, MM; Koch, MT, 2023) |
| " The authors examined the risk of developing gestational diabetes associated with the continuation of treatment with aripiprazole, ziprasidone, quetiapine, risperidone, and olanzapine during pregnancy compared with discontinuation of these antipsychotic drugs." | 3.88 | Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes. ( Bateman, BT; Cohen, JM; Cohen, LS; Desai, RJ; Glynn, RJ; Hernandez-Diaz, S; Huybrechts, KF; Mogun, H; Park, Y; Patorno, E, 2018) |
| "Rodents exposed prenatally to valproic acid (VPA) exhibit autism spectrum disorder (ASD)-like behavioral abnormalities." | 3.85 | Risperidone and aripiprazole alleviate prenatal valproic acid-induced abnormalities in behaviors and dendritic spine density in mice. ( Ago, Y; Hara, Y; Hasebe, S; Hashimoto, H; Kawase, H; Matsuda, T; Nakazawa, T; Takuma, K; Tanabe, W; Taruta, A; Tsukada, S, 2017) |
| " Among AAPDs, risperidone (RIS) ranked third after olanzapine (OLZ) and quetiapine (QUE) used during pregnancy, as OLZ is associated to substantial weight gain in adults and offspring." | 3.83 | Effects of prenatal exposure to antipsychotic risperidone on developmental neurotoxicity, apoptotic neurodegeneration and neurobehavioral sequelae in rat offspring. ( Singh, KP; Singh, M; Singh, MK, 2016) |
| "While numerous studies have confirmed the efficacy of risperidone long-acting injectable (RLAI) on many clinical outcomes in patients with schizophrenia, there is no data regarding its influence on employment status." | 3.83 | Remission and employment status in schizophrenia and other psychoses: One-year prospective study in Croatian patients treated with risperidone long acting injection. ( Emsley, R; Filipcic, IS; Grosic, V; Mihaljevic-Peles, A; Pedisic, I; Sagud, M, 2016) |
| "Overall, our data suggest that maternal inflammation may contribute to an increased risk for schizophrenia through mechanisms involving metabolic function and myelin formation and that risperidone in adolescence may prevent or reverse such changes." | 3.81 | Maternal immune activation induces changes in myelin and metabolic proteins, some of which can be prevented with risperidone in adolescence. ( Cagney, G; Cannon, M; Cotter, DR; Dicker, P; English, J; Farrelly, L; Föcking, M; Piontkewitz, Y; Wynne, K, 2015) |
| " Given the scarcity of adequate data on its prenatal toxicity, a comparative teratogenicity study of valnoctamide and two of the most commonly used drugs to treat bipolar disorder, risperidone and olanzapine, was carried out in a mouse model system." | 3.81 | Comparative teratogenicity analysis of valnoctamide, risperidone, and olanzapine in mice. ( Bialer, M; Finnell, RH; Lin, LY; Ogle, K; Wlodarczyk, BJ, 2015) |
| "The aims of this study were to investigate bone mass, body composition and light microscopic pathology examinations of femur in an animal model of schizophrenia (pharmacologically induced by postnatally administered phencyclidine-PCP) and to further examine the effects of chronic treatment with risperidone on these parameters in rats." | 3.79 | Chronic risperidone exposure does not show any evidence of bone mass deterioration in animal model of schizophrenia. ( Doknic, M; Jasovic-Gasic, M; Maric, N; Pekic, S; Petronijevic, M; Petronijevic, N; Popovic, V; Radonjic, N; Sopta, J, 2013) |
| "Perinatal phencyclidine (PCP) administration to rats represents one of the actual animal models of schizophrenia." | 3.78 | Risperidone reverses phencyclidine induced decrease in glutathione levels and alterations of antioxidant defense in rat brain. ( Doknić, M; Jevtić, G; Petronijević, ND; Popović, V; Radonjić, NV; Stojković, T; Velimirović, M, 2012) |
| " The authors report a case of a woman with schizophrenia wherein risperidone was used successfully in two consecutive pregnancies." | 3.74 | Risperidone therapy in two successive pregnancies. ( Lohia, D; Mendhekar, D, 2008) |
| "Data on the use of long-acting injectable (LAI) risperidone, the first atypical depot antipsychotic, during pregnancy are limited." | 3.74 | Use of long-acting injectable risperidone before and throughout pregnancy in schizophrenia. ( Kim, JM; Kim, KM; Kim, SW; Shin, HY; Shin, IS; Yang, SJ; Yoon, JS, 2007) |
| "The authors conducted a prospective observational study of women treated with an atypical antipsychotic or haloperidol during pregnancy." | 3.74 | Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. ( Beach, AJ; Calamaras, MR; DeVane, CL; Donovan, J; Gibson, BB; Knight, BT; Nemeroff, CB; Newport, DJ; Owens, MJ; Stowe, ZN; Viguera, AC; Winn, S, 2007) |
| "A follow-up of a case of pregnancy with risperidone microspheres is reported." | 3.73 | Follow-up of a pregnancy with risperidone microspheres. ( Dabbert, D; Heinze, M, 2006) |
| " The parturient developed exaggerated hypotension, refractory to conventional treatment with ephedrine and IV fluids, that eventually responded to large doses of phenylephrine." | 3.72 | Risperidone and exaggerated hypotension during a spinal anesthetic. ( Hepner, DL; Williams, JH, 2004) |
| "Our case (36-year old) has suffered schizophrenia (DSM-IV) for 5 years and used these drugs (risperidone, quetiapine, mirtazapine, thioridazine, diazepam, hydroxyzine, clomipramine, fluvoxamine, alprazolam, carbamazepine, biperiden, haloperidol, ampicillin+sulbactam, enoxaparin, oxerutine) in her third pregnancy." | 3.72 | Use of polypharmacotherapy in pregnancy: a prospective outcome in a case. ( Kadioglu, M; Kalyoncu, NI; Kesim, M; Ulku, C; Yaris, E; Yaris, F, 2004) |
| "Mucopolysaccharidosis IIIA (MPS IIIA) is a lysosomal storage disorder characterized by progressive mental deterioration and severe behavioral problems." | 2.75 | Clinical overview of children with mucopolysaccharidosis type III A and effect of Risperidone treatment on children and their mothers psychological status. ( Coker, M; Demiral, N; Erermis, S; Kalkan Ucar, S; Ozbaran, B; Yuncu, Z, 2010) |
| "Schizophrenia is a severe neuropsychiatric disease associated with substantially higher mortality." | 1.62 | Interacting effects of the MAM model of schizophrenia and antipsychotic treatment: Untargeted proteomics approach in adipose tissue. ( Bienertova-Vasku, J; Horska, K; Hruska, P; Kucera, J; Kuruczova, D; Micale, V; Ruda-Kucerova, J, 2021) |
| " The current report presents adverse events in an infant exposed to a combination of risperidone and haloperidol through breast milk." | 1.51 | Adverse Events in a Breastfed Infant Exposed to Risperidone and Haloperidol. ( Uguz, F, 2019) |
| "Infant delirium is an under-recognized clinical entity in neonatal intensive care, and earlier identification and treatment could minimize morbidities associated with this condition." | 1.46 | A case of infant delirium in the neonatal intensive care unit. ( Bidegain, M; Cotten, CM; Edwards, LE; Hornik, CD; Hutchison, LB; Smith, PB, 2017) |
| "Schizophrenia is associated with behavioral and brain structural abnormalities, of which the hippocampus appears to be one of the most consistent region affected." | 1.43 | Maturation- and sex-sensitive depression of hippocampal excitatory transmission in a rat schizophrenia model. ( Attali, B; Patrich, E; Peretz, A; Piontkewitz, Y; Weiner, I, 2016) |
| "Risperidone was discontinued and, owing to ongoing psychosis, olanzapine was initiated." | 1.38 | Antipsychotics leading to neuroleptic malignant syndrome in pregnancy. ( Aghajanian, P; Dossett, E; Ghaffari, N; Lee, RH, 2012) |
| "Schizophrenia is a disorder of a neurodevelopmental origin manifested symptomatically after puberty." | 1.37 | Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia. ( Arad, M; Piontkewitz, Y; Weiner, I, 2011) |
| "Transient prenatal vitamin D deficiency is considered a neurodevelopmental animal model in schizophrenia research." | 1.35 | Transient prenatal vitamin D deficiency is associated with changes of synaptic plasticity in the dentate gyrus in adult rats. ( Becker, A; Grecksch, G; Höllt, V; Rüthrich, H, 2009) |
| "Antipsychotic treatment during pregnancy is indicated when risk of drug exposure to the fetus is outweighed by the untreated psychosis in the mother." | 1.35 | Distinct neurobehavioral consequences of prenatal exposure to sulpiride (SUL) and risperidone (RIS) in rats. ( Hao, Y; Liu, H; Liu, Z; Lu, XH; Ouyang, X; Xu, L; Zuo, J, 2008) |
| "Transient prenatal Vitamin D deficiency is considered a developmental model in schizophrenia research." | 1.33 | Pharmacological treatment to augment hole board habituation in prenatal Vitamin D-deficient rats. ( Becker, A; Grecksch, G, 2006) |
| "Risperidone was the antipsychotic employed and elevation of prolactin concentrations were noted each time." | 1.32 | Delusions of pregnancy associated with increased prolactin concentrations produced by antipsychotic treatment. ( Ali, JA; Ali, LJ; Desai, KD, 2003) |
| "Family history of psychiatric illness and the presence of obstetric complications were estimated by a semistructured questionnaire." | 1.31 | Does risperidone act better in schizophrenic patients who have a family or obstetric history? ( Borkowska, A; Rybakowski, JK, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.47) | 18.2507 |
| 2000's | 22 (32.35) | 29.6817 |
| 2010's | 36 (52.94) | 24.3611 |
| 2020's | 9 (13.24) | 2.80 |
| Authors | Studies |
|---|---|
| Elnahas, EM | 2 |
| Abuelezz, SA | 1 |
| Mohamad, MI | 1 |
| Nabil, MM | 1 |
| Abdelraouf, SM | 1 |
| Bahaa, N | 1 |
| Hassan, GAM | 1 |
| Aboul-Fotouh, S | 2 |
| Lian, J | 1 |
| Han, M | 1 |
| Su, Y | 1 |
| Hodgson, J | 1 |
| Deng, C | 1 |
| Mishra, A | 1 |
| Singla, R | 1 |
| Kumar, R | 1 |
| Sharma, A | 1 |
| Joshi, R | 1 |
| Sarma, P | 1 |
| Kaur, G | 1 |
| Prajapat, M | 1 |
| Bhatia, A | 1 |
| Medhi, B | 1 |
| Mahdy, WYB | 1 |
| Yamamoto, K | 1 |
| Ito, T | 1 |
| Fujiwara, N | 1 |
| Fujioka, K | 1 |
| Horai, T | 1 |
| Otsuka, I | 1 |
| Imafuku, H | 1 |
| Omura, T | 1 |
| Iijima, K | 1 |
| Yano, I | 1 |
| Koch, MT | 1 |
| Carlson, HE | 1 |
| Kazimi, MM | 1 |
| Correll, CU | 1 |
| Habib, MZ | 1 |
| Aboul-Ela, YM | 1 |
| Ebeid, MA | 1 |
| Tarek, M | 1 |
| Sadek, DR | 1 |
| Negm, EA | 1 |
| Abdelhakam, DA | 1 |
| Amini, A | 1 |
| Namvarpour, Z | 1 |
| Namvarpour, M | 1 |
| Raoofi, A | 1 |
| Kucera, J | 1 |
| Horska, K | 1 |
| Hruska, P | 1 |
| Kuruczova, D | 1 |
| Micale, V | 1 |
| Ruda-Kucerova, J | 1 |
| Bienertova-Vasku, J | 1 |
| Rush Ortegon, E | 1 |
| Ferguson, J | 1 |
| Coffey, BJ | 1 |
| Kuppili, PP | 1 |
| Gupta, R | 1 |
| Pattanayak, RD | 1 |
| Khandelwal, SK | 1 |
| Farrelly, L | 2 |
| Rosato-Siri, MV | 1 |
| Föcking, M | 2 |
| Codagnone, M | 1 |
| Reines, A | 1 |
| Dicker, P | 2 |
| Wynne, K | 2 |
| Farrell, M | 1 |
| Cannon, M | 2 |
| Cagney, G | 2 |
| Pasquini, JM | 1 |
| Cotter, DR | 2 |
| Hara, Y | 1 |
| Ago, Y | 1 |
| Taruta, A | 1 |
| Hasebe, S | 1 |
| Kawase, H | 1 |
| Tanabe, W | 1 |
| Tsukada, S | 1 |
| Nakazawa, T | 1 |
| Hashimoto, H | 1 |
| Matsuda, T | 1 |
| Takuma, K | 1 |
| Park, Y | 1 |
| Hernandez-Diaz, S | 2 |
| Bateman, BT | 2 |
| Cohen, JM | 2 |
| Desai, RJ | 2 |
| Patorno, E | 2 |
| Glynn, RJ | 1 |
| Cohen, LS | 1 |
| Mogun, H | 2 |
| Huybrechts, KF | 2 |
| Newcomer, JW | 1 |
| Nicol, GE | 1 |
| Wang, H | 1 |
| Li, JT | 1 |
| Zhang, Y | 1 |
| Liu, R | 1 |
| Wang, XD | 1 |
| Si, TM | 1 |
| Su, YA | 1 |
| Lertxundi, U | 1 |
| Erezuma, I | 1 |
| Hernandez, R | 1 |
| Medrano, J | 1 |
| Garcia, M | 1 |
| Aguirre, C | 1 |
| Takahashi, K | 1 |
| Nakagawasai, O | 1 |
| Sakuma, W | 1 |
| Nemoto, W | 1 |
| Odaira, T | 1 |
| Lin, JR | 1 |
| Onogi, H | 1 |
| Srivastava, LK | 1 |
| Tan-No, K | 1 |
| Uguz, F | 1 |
| Petronijevic, N | 1 |
| Sopta, J | 1 |
| Doknic, M | 2 |
| Radonjic, N | 1 |
| Petronijevic, M | 1 |
| Pekic, S | 1 |
| Maric, N | 1 |
| Jasovic-Gasic, M | 1 |
| Popovic, V | 2 |
| Chatterjee, B | 1 |
| Sharan, P | 1 |
| Ennis, ZN | 1 |
| Damkier, P | 1 |
| Piontkewitz, Y | 4 |
| English, J | 1 |
| Kulkarni, J | 3 |
| Storch, A | 1 |
| Baraniuk, A | 1 |
| Gilbert, H | 1 |
| Gavrilidis, E | 1 |
| Worsley, R | 1 |
| Wlodarczyk, BJ | 1 |
| Ogle, K | 1 |
| Lin, LY | 1 |
| Bialer, M | 1 |
| Finnell, RH | 1 |
| Patrich, E | 1 |
| Peretz, A | 1 |
| Weiner, I | 3 |
| Attali, B | 1 |
| Colombel, M | 1 |
| Rebillard, C | 1 |
| Nathou, C | 1 |
| Dollfus, S | 1 |
| Singh, KP | 3 |
| Singh, MK | 3 |
| Singh, M | 1 |
| Gautam, S | 1 |
| Dejene, SZ | 1 |
| Panchaud, A | 1 |
| Cohen, L | 1 |
| Mihaljevic-Peles, A | 1 |
| Sagud, M | 1 |
| Filipcic, IS | 1 |
| Grosic, V | 1 |
| Pedisic, I | 1 |
| Emsley, R | 1 |
| Edwards, LE | 1 |
| Hutchison, LB | 1 |
| Hornik, CD | 1 |
| Smith, PB | 1 |
| Cotten, CM | 1 |
| Bidegain, M | 1 |
| Llorca, PM | 1 |
| Bouhours, P | 1 |
| Moreau-Mallet, V | 1 |
| Mendhekar, D | 1 |
| Lohia, D | 1 |
| Kalkan Ucar, S | 1 |
| Ozbaran, B | 1 |
| Demiral, N | 1 |
| Yuncu, Z | 1 |
| Erermis, S | 1 |
| Coker, M | 1 |
| Pasini, A | 1 |
| D'Agati, E | 1 |
| Casarelli, L | 1 |
| Curatolo, P | 1 |
| Grecksch, G | 2 |
| Rüthrich, H | 1 |
| Höllt, V | 1 |
| Becker, A | 2 |
| Arad, M | 1 |
| McCauley-Elsom, K | 2 |
| Gurvich, C | 1 |
| Elsom, SJ | 1 |
| Bersudsky, Y | 1 |
| Applebaum, J | 1 |
| Gaiduk, Y | 1 |
| Sharony, L | 1 |
| Mishory, A | 1 |
| Podberezsky, A | 1 |
| Agam, G | 1 |
| Belmaker, RH | 1 |
| Weggelaar, NM | 1 |
| Keijer, WJ | 1 |
| Janssen, PK | 1 |
| Richtand, NM | 3 |
| Ahlbrand, R | 3 |
| Horn, P | 1 |
| Stanford, K | 1 |
| Bronson, SL | 2 |
| McNamara, RK | 2 |
| Roenker, NL | 1 |
| Gudelsky, G | 1 |
| Kern, JR | 1 |
| Waterman, H | 1 |
| Bernstein, HG | 1 |
| Dobrowolny, H | 1 |
| Bogerts, B | 1 |
| Keilhoff, G | 1 |
| Ghaffari, N | 1 |
| Dossett, E | 1 |
| Lee, RH | 1 |
| Aghajanian, P | 1 |
| Stojković, T | 1 |
| Radonjić, NV | 1 |
| Velimirović, M | 1 |
| Jevtić, G | 1 |
| Petronijević, ND | 1 |
| Salinas Botrán, A | 1 |
| Urgelés Puértolas, D | 1 |
| Peregrin Abad, E | 1 |
| Wilson, CA | 1 |
| Terry, AV | 1 |
| Rosengarten, H | 1 |
| Quartermain, D | 1 |
| Borkowska, A | 1 |
| Rybakowski, JK | 1 |
| Ali, JA | 1 |
| Desai, KD | 1 |
| Ali, LJ | 1 |
| Williams, JH | 1 |
| Hepner, DL | 1 |
| Yaris, F | 1 |
| Yaris, E | 1 |
| Kadioglu, M | 1 |
| Ulku, C | 1 |
| Kesim, M | 1 |
| Kalyoncu, NI | 1 |
| Rueter, LE | 1 |
| Ballard, ME | 1 |
| Gallagher, KB | 1 |
| Basso, AM | 1 |
| Curzon, P | 1 |
| Kohlhaas, KL | 1 |
| Curtis, V | 1 |
| Kato, R | 1 |
| Sato, J | 1 |
| Suzuki, H | 1 |
| Taylor, B | 1 |
| Welge, JA | 1 |
| Ostrander, MM | 1 |
| Burr, J | 1 |
| Hayes, S | 1 |
| Coolen, LM | 1 |
| Pritchard, LM | 1 |
| Logue, A | 1 |
| Herman, JP | 1 |
| Kim, SW | 1 |
| Kim, KM | 1 |
| Kim, JM | 1 |
| Shin, IS | 1 |
| Shin, HY | 1 |
| Yang, SJ | 1 |
| Yoon, JS | 1 |
| Dabbert, D | 1 |
| Heinze, M | 1 |
| Coppola, D | 1 |
| Russo, LJ | 1 |
| Kwarta, RF | 1 |
| Varughese, R | 1 |
| Schmider, J | 1 |
| Newport, DJ | 1 |
| Calamaras, MR | 1 |
| DeVane, CL | 1 |
| Donovan, J | 1 |
| Beach, AJ | 1 |
| Winn, S | 1 |
| Knight, BT | 1 |
| Gibson, BB | 1 |
| Viguera, AC | 1 |
| Owens, MJ | 1 |
| Nemeroff, CB | 1 |
| Stowe, ZN | 1 |
| Zuo, J | 1 |
| Liu, Z | 1 |
| Ouyang, X | 1 |
| Liu, H | 1 |
| Hao, Y | 1 |
| Xu, L | 1 |
| Lu, XH | 1 |
| Hill, RC | 1 |
| McIvor, RJ | 1 |
| Wojnar-Horton, RE | 1 |
| Hackett, LP | 1 |
| Ilett, KF | 1 |
| Ratnayake, T | 1 |
| Libretto, SE | 1 |
| Gil-ad, I | 1 |
| Shtaif, B | 1 |
| Shiloh, R | 1 |
| Weizman, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions[NCT02292056] | 50 participants (Anticipated) | Interventional | 2013-09-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for risperidone and Pregnancy
| Article | Year |
|---|---|
Pregnancy exposure to olanzapine, quetiapine, risperidone, aripiprazole and risk of congenital malformations. A systematic review.
Topics: Abnormalities, Drug-Induced; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Female; Hum | 2015 |
Antipsychotic use in pregnancy.
Topics: Abnormalities, Drug-Induced; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Huma | 2015 |
Antipsychotics in pregnancy.
Topics: Abnormalities, Drug-Induced; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabete | 2010 |
Women are not the same as men: specific clinical issues for female patients with bipolar disorder.
Topics: Anticonvulsants; Antidepressive Agents; Benzodiazepines; Bipolar Disorder; Counseling; Dibenzothiaze | 2005 |
Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes.
Topics: Abnormalities, Drug-Induced; Abortion, Induced; Abortion, Spontaneous; Adult; Antipsychotic Agents; | 2007 |
2 trials available for risperidone and Pregnancy
| Article | Year |
|---|---|
Clinical overview of children with mucopolysaccharidosis type III A and effect of Risperidone treatment on children and their mothers psychological status.
Topics: Adolescent; Antipsychotic Agents; Child; Child Behavior Disorders; Child, Preschool; Cross-Over Stud | 2010 |
Valnoctamide as a valproate substitute with low teratogenic potential in mania: a double-blind, controlled, add-on clinical trial.
Topics: Adult; Amides; Animals; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method | 2010 |
61 other studies available for risperidone and Pregnancy
| Article | Year |
|---|---|
Novel role of peroxisome proliferator activated receptor-α in valproic acid rat model of autism: Mechanistic study of risperidone and metformin monotherapy versus combination.
Topics: Animals; Autism Spectrum Disorder; Autistic Disorder; Behavior, Animal; Disease Models, Animal; Fema | 2022 |
The long-lasting effects of early antipsychotic exposure during juvenile period on adult behaviours - A study in a poly I:C rat model.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Female; Humans; Male; Olanzapine; Poly I-C; Pregnancy; | 2022 |
Granulocyte Colony-Stimulating Factor Improved Core Symptoms of Autism Spectrum Disorder via Modulating Glutamatergic Receptors in the Prefrontal Cortex and Hippocampus of Rat Brains.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Autism Spectrum Disorder; Brain; | 2022 |
Physiologically-based pharmacokinetic model to investigate the effect of pregnancy on risperidone and paliperidone pharmacokinetics: Application to a pregnant woman and her neonate.
Topics: Adult; Child; Cytochrome P-450 CYP2D6; Female; Humans; Infant, Newborn; Models, Biological; Paliperi | 2023 |
Antipsychotic-Related Prolactin Levels and Sexual Dysfunction in Mentally Ill Youth: A 3-Month Cohort Study.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cohort Studies; Erectile Dysfunctio | 2023 |
Risperidone impedes glutamate excitotoxicity in a valproic acid rat model of autism: Role of ADAR2 in AMPA GluA2 RNA editing.
Topics: Adenosine Deaminase; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Autism Spect | 2023 |
Risperidone accelerates bone loss in rats with autistic-like deficits induced by maternal lipopolysaccharides exposure.
Topics: Animals; Animals, Newborn; Autistic Disorder; Behavior, Animal; Biomechanical Phenomena; Bone Resorp | 2020 |
Interacting effects of the MAM model of schizophrenia and antipsychotic treatment: Untargeted proteomics approach in adipose tissue.
Topics: Adipose Tissue; Animals; Antipsychotic Agents; Disease Models, Animal; Female; Haloperidol; Intra-Ab | 2021 |
A Prepubertal Girl with Delusions of Pregnancy.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Delusions; Female; Humans; Hyperprolactinemia; | 2021 |
Delusional denial of pregnancy: Unique presentation of Cotard's syndrome in a patient with schizophrenia.
Topics: Adult; Antipsychotic Agents; Delusions; Denial, Psychological; Female; Humans; Pregnancy; Pregnancy | 2017 |
The Effects of Prenatal Iron Deficiency and Risperidone Treatment on the Rat Frontal Cortex: A Proteomic Analysis.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Disease Models, Animal; Female; Frontal Lobe; Iron; | 2017 |
Risperidone and aripiprazole alleviate prenatal valproic acid-induced abnormalities in behaviors and dendritic spine density in mice.
Topics: Animals; Aripiprazole; Autism Spectrum Disorder; Dendritic Spines; Disease Models, Animal; Dopamine; | 2017 |
Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Diabetes, Gestational; Female; Humans; Olanzapine; Pipera | 2018 |
Gestational Diabetes Risk During Treatment With Antipsychotic Medications.
Topics: Antipsychotic Agents; Diabetes, Gestational; Female; Humans; Pregnancy; Risk; Risperidone | 2018 |
Prenatal Exposure to Antipsychotics Disrupts the Plasticity of Dentate Neurons and Memory in Adult Male Mice.
Topics: Animals; Antipsychotic Agents; Dentate Gyrus; Female; Haloperidol; Male; Memory; Mice, Inbred C57BL; | 2019 |
Antipsychotics and pituitary tumors: an analysis of the European pharmacovigilance database (EudraVigilance).
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Child; Databases, Factual; Female; Halop | 2019 |
Prenatal treatment with methylazoxymethanol acetate as a neurodevelopmental disruption model of schizophrenia in mice.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Clozapine; Disease Models, Animal; Fe | 2019 |
Adverse Events in a Breastfed Infant Exposed to Risperidone and Haloperidol.
Topics: Antipsychotic Agents; Dietary Exposure; Drug Therapy, Combination; Female; Haloperidol; Humans; Infa | 2019 |
Chronic risperidone exposure does not show any evidence of bone mass deterioration in animal model of schizophrenia.
Topics: Animals; Animals, Newborn; Antipsychotic Agents; Bone Density; Bone Resorption; Female; Male; Pregna | 2013 |
Tardive dyskinesia in a pregnant woman with low dose, short-duration risperidone: possible role of estrogen-induced dopaminergic hypersensitivity.
Topics: Adult; Bipolar Disorder; Dopamine Antagonists; Estrogens; Female; Humans; Movement Disorders; Pregna | 2014 |
Maternal immune activation induces changes in myelin and metabolic proteins, some of which can be prevented with risperidone in adolescence.
Topics: Aging; Animals; Antipsychotic Agents; Disease Models, Animal; Female; Male; Myelin Sheath; Prefronta | 2015 |
Comparative teratogenicity analysis of valnoctamide, risperidone, and olanzapine in mice.
Topics: Amides; Animals; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Disea | 2015 |
Maturation- and sex-sensitive depression of hippocampal excitatory transmission in a rat schizophrenia model.
Topics: Animals; Disease Models, Animal; Excitatory Postsynaptic Potentials; Female; Hippocampus; Male; Orga | 2016 |
[Can men be included in the population subjected to puerperal psychosis? A case report].
Topics: Adolescent; Affective Disorders, Psychotic; Antipsychotic Agents; Delusions; Denial, Psychological; | 2016 |
Effects of prenatal exposure to antipsychotic risperidone on developmental neurotoxicity, apoptotic neurodegeneration and neurobehavioral sequelae in rat offspring.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Annexin A5; Antipsychotic Agents; Apop | 2016 |
Effect of in utero exposure to the atypical anti-psychotic risperidone on histopathological features of the rat placenta.
Topics: Animals; Antipsychotic Agents; Female; Fetal Development; Maternal Exposure; Maternal-Fetal Exchange | 2016 |
Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations.
Topics: Abnormalities, Drug-Induced; Adult; Antipsychotic Agents; Cohort Studies; Female; Heart Defects, Con | 2016 |
Remission and employment status in schizophrenia and other psychoses: One-year prospective study in Croatian patients treated with risperidone long acting injection.
Topics: Adult; Croatia; Delayed-Action Preparations; Employment; Female; Humans; Injections, Intramuscular; | 2016 |
In utero exposure to atypical antipsychotic drug, risperidone: Effects on fetal neurotoxicity in hippocampal region and cognitive impairment in rat offspring.
Topics: Analysis of Variance; Animals; Animals, Newborn; Antipsychotic Agents; Apoptosis; Avoidance Learning | 2017 |
A case of infant delirium in the neonatal intensive care unit.
Topics: Amines; Analgesics, Opioid; Anti-Anxiety Agents; Cardiac Catheterization; Cyclohexanecarboxylic Acid | 2017 |
Improved symptom control, functioning and satisfaction in French patients treated with long-acting injectable risperidone.
Topics: Adult; Antipsychotic Agents; Catchment Area, Health; Delayed-Action Preparations; Depression, Postpa | 2008 |
Risperidone therapy in two successive pregnancies.
Topics: Antipsychotic Agents; Female; Humans; Infant, Newborn; Male; Pregnancy; Pregnancy Complications; Pre | 2008 |
Dose-dependent effect of risperidone treatment in a case of 22q13.3 deletion syndrome.
Topics: Abnormalities, Multiple; Adolescent; Aggression; Animals; Antipsychotic Agents; Chromosome Deletion; | 2010 |
Transient prenatal vitamin D deficiency is associated with changes of synaptic plasticity in the dentate gyrus in adult rats.
Topics: Animals; Dentate Gyrus; Female; Haloperidol; Long-Term Potentiation; Male; Neuronal Plasticity; Preg | 2009 |
Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia.
Topics: Age Factors; Animals; Antipsychotic Agents; Behavior, Animal; Brain; Disease Models, Animal; Female; | 2011 |
A case report of risperidone distribution and excretion into human milk: how to give good advice if you have not enough data available.
Topics: Adult; Female; Humans; Infant; Milk, Human; Patient Education as Topic; Pregnancy; Pregnancy Complic | 2011 |
Effects of risperidone and paliperidone pre-treatment on locomotor response following prenatal immune activation.
Topics: Amphetamine; Animals; Animals, Newborn; Antipsychotic Agents; Central Nervous System Stimulants; Dis | 2011 |
Effect of paliperidone and risperidone on extracellular glutamate in the prefrontal cortex of rats exposed to prenatal immune activation or MK-801.
Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Dizocilpine Maleate; Extracellular Space; Fem | 2011 |
Effects of risperidone treatment in adolescence on hippocampal neurogenesis, parvalbumin expression, and vascularization following prenatal immune activation in rats.
Topics: Animals; Bromodeoxyuridine; Female; Hippocampus; Male; Neurogenesis; Parvalbumins; Poly I-C; Pregnan | 2012 |
Antipsychotics leading to neuroleptic malignant syndrome in pregnancy.
Topics: Adult; Antipsychotic Agents; Female; Haloperidol; Humans; Neuroleptic Malignant Syndrome; Pregnancy; | 2012 |
Risperidone reverses phencyclidine induced decrease in glutathione levels and alterations of antioxidant defense in rat brain.
Topics: Animals; Antioxidants; Antipsychotic Agents; Brain; Disease Models, Animal; Female; Glutamate-Cystei | 2012 |
[Postpartum psychosis associated with cabergoline].
Topics: Adult; Antipsychotic Agents; Cabergoline; Cesarean Section; Dopamine Agonists; Ergolines; Female; Ha | 2013 |
Variable maternal stress in rats alters locomotor activity, social behavior, and recognition memory in the adult offspring.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Antipsychotic Agents; Atomoxetine Hydrochloride; | 2013 |
Effect of prenatal administration of haloperidol, risperidone, quetiapine and olanzapine on spatial learning and retention in adult rats.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Dibenzothiazepines; Drinking; Female; Haloper | 2002 |
Does risperidone act better in schizophrenic patients who have a family or obstetric history?
Topics: Adolescent; Adult; Age of Onset; Antipsychotic Agents; Cognition Disorders; Female; Humans; Male; Me | 2002 |
Delusions of pregnancy associated with increased prolactin concentrations produced by antipsychotic treatment.
Topics: Adult; Antipsychotic Agents; Benztropine; Delusions; Dibenzothiazepines; Female; Humans; Middle Aged | 2003 |
Risperidone and exaggerated hypotension during a spinal anesthetic.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Anesthesia, Spinal; Antimanic Agents | 2004 |
Use of polypharmacotherapy in pregnancy: a prospective outcome in a case.
Topics: Adult; Antipsychotic Agents; Apgar Score; Dibenzothiazepines; Drug Therapy, Combination; Female; Hum | 2004 |
Chronic low dose risperidone and clozapine alleviate positive but not negative symptoms in the rat neonatal ventral hippocampal lesion model of schizophrenia.
Topics: Acoustic Stimulation; Animals; Animals, Newborn; Antipsychotic Agents; Behavior, Animal; Clozapine; | 2004 |
[Anesthesia for cesarean section in a parturient taking risperidone and haloperidol].
Topics: Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Antipsychotic Agents; Cesarean Section; Female; | 2005 |
Risperidone pretreatment prevents elevated locomotor activity following neonatal hippocampal lesions.
Topics: Amphetamine; Animals; Animals, Newborn; Antipsychotic Agents; Circadian Rhythm; Dentate Gyrus; Dopam | 2006 |
Pharmacological treatment to augment hole board habituation in prenatal Vitamin D-deficient rats.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Exploratory Behavior; Female; Glycine; Habituation, | 2006 |
Use of long-acting injectable risperidone before and throughout pregnancy in schizophrenia.
Topics: Adult; Antipsychotic Agents; Drug Administration Schedule; Female; Humans; Injections; Pregnancy; Ri | 2007 |
Follow-up of a pregnancy with risperidone microspheres.
Topics: Adult; Antipsychotic Agents; Birth Weight; Female; Humans; Infant; Infant, Newborn; Microspheres; Pr | 2006 |
Managing psychosis in pregnancy.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Case Management; Child Custody; Cooperative Behavior; | 2007 |
Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Fetal Blood; Haloperidol; | 2007 |
Distinct neurobehavioral consequences of prenatal exposure to sulpiride (SUL) and risperidone (RIS) in rats.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Body Weight; Brain; Conditioning, Psychological; Di | 2008 |
FDA approved new drug bulletin: risperidone (risperdal).
Topics: Adult; Antipsychotic Agents; Child; Drug Interactions; Female; Humans; Isoxazoles; Patient Education | 1994 |
Risperidone distribution and excretion into human milk: case report and estimated infant exposure during breast-feeding.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Breast Feeding; Female; Humans; Infant, Newborn; Isox | 2000 |
No complications with risperidone treatment before and throughout pregnancy and during the nursing period.
Topics: Adult; Antipsychotic Agents; Female; Humans; Pregnancy; Pregnancy Complications; Pregnancy Outcome; | 2002 |
Evaluation of the neurotoxic activity of typical and atypical neuroleptics: relevance to iatrogenic extrapyramidal symptoms.
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Brain; Cell Cycle; Cell Survival; Clozapine; | 2001 |